Cargando…

Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation

BACKGROUND: We recently demonstrated that quercetin, a flavonoid naturally present in food and beverages belonging to the large class of phytochemicals, was able to sensitise leukaemic cells isolated from patients with chronic lymphocytic leukaemia (CLL) when associated with recombinant tumour necro...

Descripción completa

Detalles Bibliográficos
Autores principales: Spagnuolo, C, Cerella, C, Russo, M, Chateauvieux, S, Diederich, M, Russo, G L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142809/
https://www.ncbi.nlm.nih.gov/pubmed/21750559
http://dx.doi.org/10.1038/bjc.2011.229
_version_ 1782208860344287232
author Spagnuolo, C
Cerella, C
Russo, M
Chateauvieux, S
Diederich, M
Russo, G L
author_facet Spagnuolo, C
Cerella, C
Russo, M
Chateauvieux, S
Diederich, M
Russo, G L
author_sort Spagnuolo, C
collection PubMed
description BACKGROUND: We recently demonstrated that quercetin, a flavonoid naturally present in food and beverages belonging to the large class of phytochemicals, was able to sensitise leukaemic cells isolated from patients with chronic lymphocytic leukaemia (CLL) when associated with recombinant tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) or anti-CD95. We also showed that quercetin potentiated the effect of fludarabine on resistant B cells from CLL patients. Resistance to therapy in CLL depends on the expression and activity of anti-apoptotic proteins of the Bcl-2 family. Among these, myeloid cell leukaemia-1 (Mcl-1) has been associated with apoptotic resistance in CLL. Therefore, we investigate here whether the sensitising activity of this flavonoid, which leads to increased apoptosis in both cell lines and CLL, could be related to Mcl-1 expression and stability. RESULTS: B cells isolated from CLL patients showed different levels of Mcl-1 protein expression, resulting, in several cases, in increased sensitivity to fludarabine. Quercetin significantly enhanced the downregulation of Mcl-1 in B cells isolated from selected patients expressing detectable levels of Mcl-1. In U-937 cells, quercetin increased Mcl-1 mRNA instability in the presence of actinomycin D. When cells were treated with MG-132, a proteasome inhibitor, Mcl-1 protein level increased. However, quercetin, in the presence of Z-Vad-FMK, continued to lower Mcl-1 protein expression, indicating its independence from caspase-mediated degradation. In contrast, co-treatment of quercetin and MG-132 did not revert the effect of MG-132 mono-treatment, thus suggesting a possible interference of quercetin in regulating the proteasome-dependent degradation of Mcl-1. Gossypol, a small-molecule inhibitor of Bcl-2 family members, mimics the activity of quercetin by lowering Mcl-1 expression and sensitising U-937 cells to apoptosis induced by recombinant TRAIL and the Fas-ligand. CONCLUSION: This study demonstrates that in U-937 cells, quercetin downregulates Mcl-1 acting directly or indirectly on its mRNA stability and protein degradation, suggesting that the same mechanism may bypass resistance to apoptosis in leukaemic cells isolated from CLL patients and sensitise B cells to apoptosis induced by drugs and death receptor inducers.
format Online
Article
Text
id pubmed-3142809
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-31428092012-07-12 Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation Spagnuolo, C Cerella, C Russo, M Chateauvieux, S Diederich, M Russo, G L Br J Cancer Translational Therapeutics BACKGROUND: We recently demonstrated that quercetin, a flavonoid naturally present in food and beverages belonging to the large class of phytochemicals, was able to sensitise leukaemic cells isolated from patients with chronic lymphocytic leukaemia (CLL) when associated with recombinant tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) or anti-CD95. We also showed that quercetin potentiated the effect of fludarabine on resistant B cells from CLL patients. Resistance to therapy in CLL depends on the expression and activity of anti-apoptotic proteins of the Bcl-2 family. Among these, myeloid cell leukaemia-1 (Mcl-1) has been associated with apoptotic resistance in CLL. Therefore, we investigate here whether the sensitising activity of this flavonoid, which leads to increased apoptosis in both cell lines and CLL, could be related to Mcl-1 expression and stability. RESULTS: B cells isolated from CLL patients showed different levels of Mcl-1 protein expression, resulting, in several cases, in increased sensitivity to fludarabine. Quercetin significantly enhanced the downregulation of Mcl-1 in B cells isolated from selected patients expressing detectable levels of Mcl-1. In U-937 cells, quercetin increased Mcl-1 mRNA instability in the presence of actinomycin D. When cells were treated with MG-132, a proteasome inhibitor, Mcl-1 protein level increased. However, quercetin, in the presence of Z-Vad-FMK, continued to lower Mcl-1 protein expression, indicating its independence from caspase-mediated degradation. In contrast, co-treatment of quercetin and MG-132 did not revert the effect of MG-132 mono-treatment, thus suggesting a possible interference of quercetin in regulating the proteasome-dependent degradation of Mcl-1. Gossypol, a small-molecule inhibitor of Bcl-2 family members, mimics the activity of quercetin by lowering Mcl-1 expression and sensitising U-937 cells to apoptosis induced by recombinant TRAIL and the Fas-ligand. CONCLUSION: This study demonstrates that in U-937 cells, quercetin downregulates Mcl-1 acting directly or indirectly on its mRNA stability and protein degradation, suggesting that the same mechanism may bypass resistance to apoptosis in leukaemic cells isolated from CLL patients and sensitise B cells to apoptosis induced by drugs and death receptor inducers. Nature Publishing Group 2011-07-12 2011-07-12 /pmc/articles/PMC3142809/ /pubmed/21750559 http://dx.doi.org/10.1038/bjc.2011.229 Text en Copyright © 2011 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Translational Therapeutics
Spagnuolo, C
Cerella, C
Russo, M
Chateauvieux, S
Diederich, M
Russo, G L
Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation
title Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation
title_full Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation
title_fullStr Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation
title_full_unstemmed Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation
title_short Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation
title_sort quercetin downregulates mcl-1 by acting on mrna stability and protein degradation
topic Translational Therapeutics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142809/
https://www.ncbi.nlm.nih.gov/pubmed/21750559
http://dx.doi.org/10.1038/bjc.2011.229
work_keys_str_mv AT spagnuoloc quercetindownregulatesmcl1byactingonmrnastabilityandproteindegradation
AT cerellac quercetindownregulatesmcl1byactingonmrnastabilityandproteindegradation
AT russom quercetindownregulatesmcl1byactingonmrnastabilityandproteindegradation
AT chateauvieuxs quercetindownregulatesmcl1byactingonmrnastabilityandproteindegradation
AT diederichm quercetindownregulatesmcl1byactingonmrnastabilityandproteindegradation
AT russogl quercetindownregulatesmcl1byactingonmrnastabilityandproteindegradation